Healthcare

Pharmaceuticals Medical Devices Biotechnology Pharmaceutical Industry Health Insurance Healthcare Companies Medical Technology Insurance Healthcare Services Healthcare Providers

Novo Nordisk Lifts Outlook After Wegovy Pill Powers Big Q1 Beat

Price cuts threaten to blunt the payoff from surging prescriptions.

Lifecore Reaffirms 2026 Outlook After Q1 Adds Three Site Transfers

Dentsply Sirona Posts Q1 Revenue of $880 Million, Reaffirms 2026 Outlook

Insulet Beats Q1 Targets and Raises 2026 Outlook on Surging Omnipod Sales

Tempus AI Beats Q1, Nudges 2026 Outlook as Shares Fall After Hours

Stories older than 24h

UPMC Reaches Definitive Deal to Acquire Ohio’s Trinity Health System From CommonSpirit

Bayridge and No Fear Counselling Merge Under Ch’íyáqtel Wellness

ADC Therapeutics Reports Higher Q1 Sales and Lower Costs as Zenlonta Readouts Near

Cryoport Raises 2026 Outlook After 16% Q1 Sales Gain

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Biodesix Lifts 2026 Outlook After Q1 Revenue Jumps 42%

Embecta Releases Q2 Fiscal 2026 Results

Purdue Pharma Shuts Down as $7.4 Billion Opioid Settlement Takes Effect

Veeva Systems to Join S&P 500, Replacing Coterra Energy

Senseonics Prices $80 Million Offering to Fuel Eversense 365 Rollout

Cigna to Exit ACA Individual Market at Year-End, Affecting 369,000 Members

Cerus Raises 2026 Outlook After 24% Q1 Product Revenue Jump as INT200 Filing Nears

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

Analysts Trim Targets, Still Back Boston Scientific